Replicel Investor Relations
RepliCel is a regenerative medicine company focused on rejuvenating hair growth, restoring damaged skin, and repairing chronically injured tendons. Each of these conditions is caused by a deficit of healthy, active cells required for normal healing and function. The company’s autologous cell therapies address these cellular deficits with the injection of new cells manufactured for and delivered to address the specific clinical need.